Report Detail
Global Nano-based Drug Delivery System Market Growth (Status and Outlook) 2022-2028
- RnM4495273 |
- 15 November, 2022 |
- Global |
- 121 Pages |
- LPI(LP Information) |
- Medical Industry
The global market for Nano-based Drug Delivery System is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
The APAC Nano-based Drug Delivery System market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The United States Nano-based Drug Delivery System market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The Europe Nano-based Drug Delivery System market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The China Nano-based Drug Delivery System market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
Global key Nano-based Drug Delivery System players cover Amgen, Teva, Roche, UCB (Union Chimique Belge) and Celgene, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
Report Coverage
This latest report provides a deep insight into the global Nano-based Drug Delivery System market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.
This report aims to provide a comprehensive picture of the global Nano-based Drug Delivery System market, with both quantitative and qualitative data, to help readers understand how the Nano-based Drug Delivery System market scenario changed across the globe during the pandemic and Russia-Ukraine War.
The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions.
Market Segmentation:
The study segments the Nano-based Drug Delivery System market and forecasts the market size by Type (Less than 50nm, 50-150nm and 150-300nm), by Application (Hydrophilic Drugs and Hydrophobic Drugs.), and region (APAC, Americas, Europe, and Middle East & Africa).
Segmentation by type
Less than 50nm
50-150nm
150-300nm
Others
Segmentation by application
Hydrophilic Drugs
Hydrophobic Drugs
Segmentation by region
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
Major companies covered
Amgen
Teva
Roche
UCB (Union Chimique Belge)
Celgene
Merck
Gilead Sciences
Sanofi
Pfizer
Takeda
Bausch&Lomb
Samyang Biopharmaceuticals
Johnson & Johnson
TOLMAR
Astellas
AMAG Pharmaceuticals
AbbVie
Dr Reddy
AstraZeneca
Aspen
Acrotech Biopharma
TWi Pharmaceuticals
Chapter Introduction
Chapter 1: Scope of Nano-based Drug Delivery System, Research Methodology, etc.
Chapter 2: Executive Summary, global Nano-based Drug Delivery System market size and CAGR, Nano-based Drug Delivery System market size by region, by type, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: Nano-based Drug Delivery System revenue, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global Nano-based Drug Delivery System revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, revenue segment by country, by type, and application.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global Nano-based Drug Delivery System market size forecast by region, by country, by type, and application
Chapter 13: Comprehensive company profiles of the leading players, including Amgen, Teva, Roche, UCB (Union Chimique Belge), Celgene, Merck, Gilead Sciences, Sanofi and Pfizer, etc.
Chapter 14: Research Findings and Conclusion
1 Scope of the Report
- 1.1 Market Introduction
- 1.2 Years Considered
- 1.3 Research Objectives
- 1.4 Market Research Methodology
- 1.5 Research Process and Data Source
- 1.6 Economic Indicators
- 1.7 Currency Considered
2 Executive Summary
- 2.1 World Market Overview
- 2.1.1 Global Nano-based Drug Delivery System Market Size 2017-2028
- 2.1.2 Nano-based Drug Delivery System Market Size CAGR by Region 2017 VS 2022 VS 2028
- 2.2 Nano-based Drug Delivery System Segment by Type
- 2.2.1 Less than 50nm
- 2.2.2 50-150nm
- 2.2.3 150-300nm
- 2.2.4 Others
- 2.3 Nano-based Drug Delivery System Market Size by Type
- 2.3.1 Nano-based Drug Delivery System Market Size CAGR by Type (2017 VS 2022 VS 2028)
- 2.3.2 Global Nano-based Drug Delivery System Market Size Market Share by Type (2017-2022)
- 2.4 Nano-based Drug Delivery System Segment by Application
- 2.4.1 Hydrophilic Drugs
- 2.4.2 Hydrophobic Drugs
- 2.5 Nano-based Drug Delivery System Market Size by Application
- 2.5.1 Nano-based Drug Delivery System Market Size CAGR by Application (2017 VS 2022 VS 2028)
- 2.5.2 Global Nano-based Drug Delivery System Market Size Market Share by Application (2017-2022)
3 Nano-based Drug Delivery System Market Size by Player
- 3.1 Nano-based Drug Delivery System Market Size Market Share by Players
- 3.1.1 Global Nano-based Drug Delivery System Revenue by Players (2020-2022)
- 3.1.2 Global Nano-based Drug Delivery System Revenue Market Share by Players (2020-2022)
- 3.2 Global Nano-based Drug Delivery System Key Players Head office and Products Offered
- 3.3 Market Concentration Rate Analysis
- 3.3.1 Competition Landscape Analysis
- 3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
- 3.4 New Products and Potential Entrants
- 3.5 Mergers & Acquisitions, Expansion
4 Nano-based Drug Delivery System by Regions
- 4.1 Nano-based Drug Delivery System Market Size by Regions (2017-2022)
- 4.2 Americas Nano-based Drug Delivery System Market Size Growth (2017-2022)
- 4.3 APAC Nano-based Drug Delivery System Market Size Growth (2017-2022)
- 4.4 Europe Nano-based Drug Delivery System Market Size Growth (2017-2022)
- 4.5 Middle East & Africa Nano-based Drug Delivery System Market Size Growth (2017-2022)
5 Americas
- 5.1 Americas Nano-based Drug Delivery System Market Size by Country (2017-2022)
- 5.2 Americas Nano-based Drug Delivery System Market Size by Type (2017-2022)
- 5.3 Americas Nano-based Drug Delivery System Market Size by Application (2017-2022)
- 5.4 United States
- 5.5 Canada
- 5.6 Mexico
- 5.7 Brazil
6 APAC
- 6.1 APAC Nano-based Drug Delivery System Market Size by Region (2017-2022)
- 6.2 APAC Nano-based Drug Delivery System Market Size by Type (2017-2022)
- 6.3 APAC Nano-based Drug Delivery System Market Size by Application (2017-2022)
- 6.4 China
- 6.5 Japan
- 6.6 Korea
- 6.7 Southeast Asia
- 6.8 India
- 6.9 Australia
7 Europe
- 7.1 Europe Nano-based Drug Delivery System by Country (2017-2022)
- 7.2 Europe Nano-based Drug Delivery System Market Size by Type (2017-2022)
- 7.3 Europe Nano-based Drug Delivery System Market Size by Application (2017-2022)
- 7.4 Germany
- 7.5 France
- 7.6 UK
- 7.7 Italy
- 7.8 Russia
8 Middle East & Africa
- 8.1 Middle East & Africa Nano-based Drug Delivery System by Region (2017-2022)
- 8.2 Middle East & Africa Nano-based Drug Delivery System Market Size by Type (2017-2022)
- 8.3 Middle East & Africa Nano-based Drug Delivery System Market Size by Application (2017-2022)
- 8.4 Egypt
- 8.5 South Africa
- 8.6 Israel
- 8.7 Turkey
- 8.8 GCC Countries
9 Market Drivers, Challenges and Trends
- 9.1 Market Drivers & Growth Opportunities
- 9.2 Market Challenges & Risks
- 9.3 Industry Trends
10 Global Nano-based Drug Delivery System Market Forecast
- 10.1 Global Nano-based Drug Delivery System Forecast by Regions (2023-2028)
- 10.1.1 Global Nano-based Drug Delivery System Forecast by Regions (2023-2028)
- 10.1.2 Americas Nano-based Drug Delivery System Forecast
- 10.1.3 APAC Nano-based Drug Delivery System Forecast
- 10.1.4 Europe Nano-based Drug Delivery System Forecast
- 10.1.5 Middle East & Africa Nano-based Drug Delivery System Forecast
- 10.2 Americas Nano-based Drug Delivery System Forecast by Country (2023-2028)
- 10.2.1 United States Nano-based Drug Delivery System Market Forecast
- 10.2.2 Canada Nano-based Drug Delivery System Market Forecast
- 10.2.3 Mexico Nano-based Drug Delivery System Market Forecast
- 10.2.4 Brazil Nano-based Drug Delivery System Market Forecast
- 10.3 APAC Nano-based Drug Delivery System Forecast by Region (2023-2028)
- 10.3.1 China Nano-based Drug Delivery System Market Forecast
- 10.3.2 Japan Nano-based Drug Delivery System Market Forecast
- 10.3.3 Korea Nano-based Drug Delivery System Market Forecast
- 10.3.4 Southeast Asia Nano-based Drug Delivery System Market Forecast
- 10.3.5 India Nano-based Drug Delivery System Market Forecast
- 10.3.6 Australia Nano-based Drug Delivery System Market Forecast
- 10.4 Europe Nano-based Drug Delivery System Forecast by Country (2023-2028)
- 10.4.1 Germany Nano-based Drug Delivery System Market Forecast
- 10.4.2 France Nano-based Drug Delivery System Market Forecast
- 10.4.3 UK Nano-based Drug Delivery System Market Forecast
- 10.4.4 Italy Nano-based Drug Delivery System Market Forecast
- 10.4.5 Russia Nano-based Drug Delivery System Market Forecast
- 10.5 Middle East & Africa Nano-based Drug Delivery System Forecast by Region (2023-2028)
- 10.5.1 Egypt Nano-based Drug Delivery System Market Forecast
- 10.5.2 South Africa Nano-based Drug Delivery System Market Forecast
- 10.5.3 Israel Nano-based Drug Delivery System Market Forecast
- 10.5.4 Turkey Nano-based Drug Delivery System Market Forecast
- 10.5.5 GCC Countries Nano-based Drug Delivery System Market Forecast
- 10.6 Global Nano-based Drug Delivery System Forecast by Type (2023-2028)
- 10.7 Global Nano-based Drug Delivery System Forecast by Application (2023-2028)
11 Key Players Analysis
- 11.1 Amgen
- 11.1.1 Amgen Company Information
- 11.1.2 Amgen Nano-based Drug Delivery System Product Offered
- 11.1.3 Amgen Nano-based Drug Delivery System Revenue, Gross Margin and Market Share (2020-2022)
- 11.1.4 Amgen Main Business Overview
- 11.1.5 Amgen Latest Developments
- 11.2 Teva
- 11.2.1 Teva Company Information
- 11.2.2 Teva Nano-based Drug Delivery System Product Offered
- 11.2.3 Teva Nano-based Drug Delivery System Revenue, Gross Margin and Market Share (2020-2022)
- 11.2.4 Teva Main Business Overview
- 11.2.5 Teva Latest Developments
- 11.3 Roche
- 11.3.1 Roche Company Information
- 11.3.2 Roche Nano-based Drug Delivery System Product Offered
- 11.3.3 Roche Nano-based Drug Delivery System Revenue, Gross Margin and Market Share (2020-2022)
- 11.3.4 Roche Main Business Overview
- 11.3.5 Roche Latest Developments
- 11.4 UCB (Union Chimique Belge)
- 11.4.1 UCB (Union Chimique Belge) Company Information
- 11.4.2 UCB (Union Chimique Belge) Nano-based Drug Delivery System Product Offered
- 11.4.3 UCB (Union Chimique Belge) Nano-based Drug Delivery System Revenue, Gross Margin and Market Share (2020-2022)
- 11.4.4 UCB (Union Chimique Belge) Main Business Overview
- 11.4.5 UCB (Union Chimique Belge) Latest Developments
- 11.5 Celgene
- 11.5.1 Celgene Company Information
- 11.5.2 Celgene Nano-based Drug Delivery System Product Offered
- 11.5.3 Celgene Nano-based Drug Delivery System Revenue, Gross Margin and Market Share (2020-2022)
- 11.5.4 Celgene Main Business Overview
- 11.5.5 Celgene Latest Developments
- 11.6 Merck
- 11.6.1 Merck Company Information
- 11.6.2 Merck Nano-based Drug Delivery System Product Offered
- 11.6.3 Merck Nano-based Drug Delivery System Revenue, Gross Margin and Market Share (2020-2022)
- 11.6.4 Merck Main Business Overview
- 11.6.5 Merck Latest Developments
- 11.7 Gilead Sciences
- 11.7.1 Gilead Sciences Company Information
- 11.7.2 Gilead Sciences Nano-based Drug Delivery System Product Offered
- 11.7.3 Gilead Sciences Nano-based Drug Delivery System Revenue, Gross Margin and Market Share (2020-2022)
- 11.7.4 Gilead Sciences Main Business Overview
- 11.7.5 Gilead Sciences Latest Developments
- 11.8 Sanofi
- 11.8.1 Sanofi Company Information
- 11.8.2 Sanofi Nano-based Drug Delivery System Product Offered
- 11.8.3 Sanofi Nano-based Drug Delivery System Revenue, Gross Margin and Market Share (2020-2022)
- 11.8.4 Sanofi Main Business Overview
- 11.8.5 Sanofi Latest Developments
- 11.9 Pfizer
- 11.9.1 Pfizer Company Information
- 11.9.2 Pfizer Nano-based Drug Delivery System Product Offered
- 11.9.3 Pfizer Nano-based Drug Delivery System Revenue, Gross Margin and Market Share (2020-2022)
- 11.9.4 Pfizer Main Business Overview
- 11.9.5 Pfizer Latest Developments
- 11.10 Takeda
- 11.10.1 Takeda Company Information
- 11.10.2 Takeda Nano-based Drug Delivery System Product Offered
- 11.10.3 Takeda Nano-based Drug Delivery System Revenue, Gross Margin and Market Share (2020-2022)
- 11.10.4 Takeda Main Business Overview
- 11.10.5 Takeda Latest Developments
- 11.11 Bausch&Lomb
- 11.11.1 Bausch&Lomb Company Information
- 11.11.2 Bausch&Lomb Nano-based Drug Delivery System Product Offered
- 11.11.3 Bausch&Lomb Nano-based Drug Delivery System Revenue, Gross Margin and Market Share (2020-2022)
- 11.11.4 Bausch&Lomb Main Business Overview
- 11.11.5 Bausch&Lomb Latest Developments
- 11.12 Samyang Biopharmaceuticals
- 11.12.1 Samyang Biopharmaceuticals Company Information
- 11.12.2 Samyang Biopharmaceuticals Nano-based Drug Delivery System Product Offered
- 11.12.3 Samyang Biopharmaceuticals Nano-based Drug Delivery System Revenue, Gross Margin and Market Share (2020-2022)
- 11.12.4 Samyang Biopharmaceuticals Main Business Overview
- 11.12.5 Samyang Biopharmaceuticals Latest Developments
- 11.13 Johnson & Johnson
- 11.13.1 Johnson & Johnson Company Information
- 11.13.2 Johnson & Johnson Nano-based Drug Delivery System Product Offered
- 11.13.3 Johnson & Johnson Nano-based Drug Delivery System Revenue, Gross Margin and Market Share (2020-2022)
- 11.13.4 Johnson & Johnson Main Business Overview
- 11.13.5 Johnson & Johnson Latest Developments
- 11.14 TOLMAR
- 11.14.1 TOLMAR Company Information
- 11.14.2 TOLMAR Nano-based Drug Delivery System Product Offered
- 11.14.3 TOLMAR Nano-based Drug Delivery System Revenue, Gross Margin and Market Share (2020-2022)
- 11.14.4 TOLMAR Main Business Overview
- 11.14.5 TOLMAR Latest Developments
- 11.15 Astellas
- 11.15.1 Astellas Company Information
- 11.15.2 Astellas Nano-based Drug Delivery System Product Offered
- 11.15.3 Astellas Nano-based Drug Delivery System Revenue, Gross Margin and Market Share (2020-2022)
- 11.15.4 Astellas Main Business Overview
- 11.15.5 Astellas Latest Developments
- 11.16 AMAG Pharmaceuticals
- 11.16.1 AMAG Pharmaceuticals Company Information
- 11.16.2 AMAG Pharmaceuticals Nano-based Drug Delivery System Product Offered
- 11.16.3 AMAG Pharmaceuticals Nano-based Drug Delivery System Revenue, Gross Margin and Market Share (2020-2022)
- 11.16.4 AMAG Pharmaceuticals Main Business Overview
- 11.16.5 AMAG Pharmaceuticals Latest Developments
- 11.17 AbbVie
- 11.17.1 AbbVie Company Information
- 11.17.2 AbbVie Nano-based Drug Delivery System Product Offered
- 11.17.3 AbbVie Nano-based Drug Delivery System Revenue, Gross Margin and Market Share (2020-2022)
- 11.17.4 AbbVie Main Business Overview
- 11.17.5 AbbVie Latest Developments
- 11.18 Dr Reddy
- 11.18.1 Dr Reddy Company Information
- 11.18.2 Dr Reddy Nano-based Drug Delivery System Product Offered
- 11.18.3 Dr Reddy Nano-based Drug Delivery System Revenue, Gross Margin and Market Share (2020-2022)
- 11.18.4 Dr Reddy Main Business Overview
- 11.18.5 Dr Reddy Latest Developments
- 11.19 AstraZeneca
- 11.19.1 AstraZeneca Company Information
- 11.19.2 AstraZeneca Nano-based Drug Delivery System Product Offered
- 11.19.3 AstraZeneca Nano-based Drug Delivery System Revenue, Gross Margin and Market Share (2020-2022)
- 11.19.4 AstraZeneca Main Business Overview
- 11.19.5 AstraZeneca Latest Developments
- 11.20 Aspen
- 11.20.1 Aspen Company Information
- 11.20.2 Aspen Nano-based Drug Delivery System Product Offered
- 11.20.3 Aspen Nano-based Drug Delivery System Revenue, Gross Margin and Market Share (2020-2022)
- 11.20.4 Aspen Main Business Overview
- 11.20.5 Aspen Latest Developments
- 11.21 Acrotech Biopharma
- 11.21.1 Acrotech Biopharma Company Information
- 11.21.2 Acrotech Biopharma Nano-based Drug Delivery System Product Offered
- 11.21.3 Acrotech Biopharma Nano-based Drug Delivery System Revenue, Gross Margin and Market Share (2020-2022)
- 11.21.4 Acrotech Biopharma Main Business Overview
- 11.21.5 Acrotech Biopharma Latest Developments
- 11.22 TWi Pharmaceuticals
- 11.22.1 TWi Pharmaceuticals Company Information
- 11.22.2 TWi Pharmaceuticals Nano-based Drug Delivery System Product Offered
- 11.22.3 TWi Pharmaceuticals Nano-based Drug Delivery System Revenue, Gross Margin and Market Share (2020-2022)
- 11.22.4 TWi Pharmaceuticals Main Business Overview
- 11.22.5 TWi Pharmaceuticals Latest Developments
12 Research Findings and Conclusion
Summary:
Get latest Market Research Reports on Nano-based Drug Delivery System. Industry analysis & Market Report on Nano-based Drug Delivery System is a syndicated market report, published as Global Nano-based Drug Delivery System Market Growth (Status and Outlook) 2022-2028. It is complete Research Study and Industry Analysis of Nano-based Drug Delivery System market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
